BS:FLRY3 Fleury S.A

Fleury S.A., together with its subsidiaries, provides medical services for diagnostic, treatment, and clinical testing areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It offers diagnostic information, reference laboratory, and dental diagnostic imaging services. The company also promotes conditions for the development of the medical profession, and supports research and studies for the scientific progress of medicine. As of March 31, 2017, the company had 145 patient service centers and 22 operations in hospitals under the Fleury, Weinmann, Clínica Felippe Mattoso, a+, Labs a+, and Diagnoson a+ brand names. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

14.33 BRL
As of 03/22/2023

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  Brazil
Country of incorporation:  Brazil
IPO date:  12/17/2009
Stock exchange:    XBSP
Exchange country:   Brazil
Market cap:   4,646,765,568 BRL
Current dividend yield:   4.82%
Sedol:      B4X4D29